INTERNATIONAL PATENT: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY, 광주과학기술원, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교 산학협력단, NATIONAL CANCER CENTER, 국립암센터, SEOUL NATIONAL UNIVERSITY HOSPITAL, 서울대학교병원 FILES APPLICATION FOR "NOVEL PRES1 DERIVATIVE COMPOUND INHIBITING HOST ENTRY OF HEPATITIS B VIRUS"

GENEVA, Jan. 13 -- GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (123 Cheomdangwagi-roBuk-guGwangju 61005), 광주과학기술원 (광주광역시북구첨단과기로 123), SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1 Gwanak-roGwanak-guSeoul 08826), 서울대학교 산학협력단 (서울특별시관악구관악로 1), NATIONAL CANCER CENTER (323, Ilsan-roIlsandong-gu, Goyang-siGyeonggi-do 10408), 국립암센터 (경기도고양시 일산동구일산로 32...